尝试通过次溴酸钾对噻唑-4,5-二甲酰胺的作用制备噻唑并[4,5- d ]嘧啶-5,7-二醇的方法表明,当2-取代基被取代时,该稠环系统的噻唑部分不稳定。不足。与先前的报道相反,获得的产物是双-(4-氨基-2,6-二氢嘧啶-5-基)二硫化物。通过将相应的4-氨基嘧啶-5-基硫氰酸酯环化,已经制备了许多噻唑洛[4,5- d ]嘧啶。用亚硝酸对氨基噻唑并[4,5- d ]嘧啶进行脱氨基反应,得到了许多衍生物,其中之一是尿酸的类似物。
Thiazolopyrimidines and thier use as modulators of chemokine receptor activity
申请人:——
公开号:US20030032642A1
公开(公告)日:2003-02-13
The invention provides certain thiazolopyrimidine compound, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
本发明提供了某些噻唑嘧啶化合物、其制备过程和中间体、含有它们的药物组合物以及它们在治疗中的用途。
NOVEL THIAZOLOPYRIMIDINE COMPOUNDS
申请人:AstraZeneca AB
公开号:EP1104425B1
公开(公告)日:2003-01-29
Studies on Condensed Pyrimidine Systems. VI. Some 2-Aminothiazolo [4,5-d]-pyrimidines<sup>1,2</sup>
作者:Allison Maggiolo、George H. Hitchings
DOI:10.1021/ja01153a055
日期:1951.9
THIAZOLOPYRIMIDINES AND THEIR USE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY